Our mission is to help people see more clearly and improve their quality of life.

Our technology is clinically proven to improve vision across a variety of vision conditions and is FDA-cleared for amblyopia over age 9. RevitalVision enhances the brain's visual processing, enabling significant vision improvements beyond standard eye care, truly making a difference

Meet the Team

Yair Yahav
Founder & CEO
Yogev Shamay
Co-founder & CTO
Yuval Ron-Ruhama
COO
Charles Morris
General Manager –N. America
Yonina Thee
Clinical Specialist
Inbal Sasson
Clinical Research Manager
Shlomo Abramson
Clinical Service Manager
Rona Erlich
Marketing Director

Board

Yariv Baron
Director
Dr. Shulamit Hadi
Director
Alon Reshef
Director & Shareholder
Simon Kan
Director

Advisory Board

Amir Belson, M.D.
Advisory Board
Prof. Richard W. Hertle (MD)
Scientific & Clinical Advisor
Prof. Ramesh

Kekunnaya (MD)
Scientific & Clinical Advisor
Dr. Sarah Maling (MD)
Advisory Board
Mike Turner
Advisory Board
Prof. Yair Morad (MD)
Scientific & Clinical Advisor

Latest News and Events

News icon

March 2022

RevitalVision will present at the AAPOS 2022 – Arizona

2022 Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS), on March 23-27, 2022.

News icon

RevitalVision at HIMSS 22

This year, the Israel Export Institute together with the Foreign Trade Administration – Ministry of Economy & Industry will present 18Israeli Digital Health companies. And we are proud to be amongst these innovative companies

News icon

November 2021

RevitalVision on The Ophthalmologist

Yair Yahav, CEO and founder of RevitalVision, was interviewed in The Ophthalmologist about how we improve vision in adult amblyopia

News icon

3-6 November 2021

American Academy of Optometry Annual Meeting

We’re excited to be one of the exhibitors at the American Academy of Optometry Annual Meeting – which will be taking place in Boston. Visit us in the exhibit hall at booth #843

Academy2021-Logo-
News icon

12-15 November 2021

American Academy of Ophthalmology Annual Meeting

Come meet our experts at the AAO annual meeting, taking place in New Orleans this November

American academy of phathlmology banner
News icon

July 2021

RevitalVision received reimbursement code in the USA

RevitalVision is a standalone therapeutic vision training software, the only FDA-approved product for market, and clinically proven to improve vision in adult amblyopia (age 9-plus), received a unique Current Procedural Terminology (CPT) reimbursement code from the American Medical Association (AMA).

AMA logo
1 3 4 5 6 7